PMID: 8986328Dec 1, 1996Paper

Slow-wave activity in the spectral analysis of the electroencephalogram and volumes of hippocampus in subgroups of Alzheimer's disease patients

Behavioral Neuroscience
E L HelkalaP J Riekkinen

Abstract

This study examined patients who fulfilled the National Institute of Neurological and Communicative Disorders and Stroke/Alzheimer's Disease and Related Disorders Association Work Group criteria for probable Alzheimer's disease (AD; n = 35) and controls for magnetic resonance imaging and psychometric data (n = 16) and for quantitative electroencephalogram data (n = 34). A cluster analysis performed on neuropsychological variables identified 2 AD subgroups: The AD1 group (n = 12) had impaired memory and executive functions but preserved verbal and visuospatial functions. The AD2 group (n = 23) had global impairment. The AD2 group had higher theta amplitude in the temporo-occipital, centroparietal, and frontal derivation and lower peak and mean frequency than the AD1 group or controls. Both AD groups had more severe memory deficits and clearly smaller hippocampal volumes than controls. This may implicate that the degree of damage in ascending activating systems differs in these subgroups, although the damage in the hippocampus is equal.

Citations

Jan 28, 2004·Neuropsychology·Lynette J TippettSharon L Thompson-Schill
Jul 4, 2001·Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society·M GrunwaldH J Gertz
Jun 2, 2011·International Journal of Alzheimer's Disease·Roberta LizioClaudio Babiloni
May 28, 2014·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·Claudio BabiloniMassimo Andreoni
Jul 10, 2012·International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology·Fabrizio VecchioPaolo M Rossini
Jul 6, 2007·The European Journal of Neuroscience·Claudio BabiloniPaolo M Rossini
Apr 7, 2007·Annals of the New York Academy of Sciences·Leslie S Prichep
Jun 11, 2011·International Journal of Alzheimer's Disease·François-B VialatteAndrzej Cichocki
Mar 9, 2017·Journal of Alzheimer's Disease : JAD·Max Toepper
Jun 21, 2012·Clinical EEG and Neuroscience·Pål G LarssonGöran Lantz
Jun 6, 2020·PloS One·Aruane M PinedaAndriana S L O Campanharo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Neuroimaging

Neuroimaging can help identify pathological hallmarks of Alzheimer's disease (AD). Here is the latest research on neuroimaging modalities, including magnetic resonance imaging and positron emission tomography, in AD.